Preview Mode Links will not work in preview mode

Aug 31, 2021

Featuring slide presentations and related discussion from Drs Petros Grivas, Daniel P Petrylak and Arlene Siefker-Radtke, including the following topics:

  • Key Data Supporting the Use of Antibody-Drug Conjugates in Bladder Cancer — Daniel P Petrylak, MD (0:00)
  • Approved and Investigational FGFR-Targeted Therapies in Advanced Urothelial Bladder Cancer — Arlene Siefker-Radtke, MD (33:01)
  • Current and Future Role of Immune Checkpoint Inhibitors in Urothelial Bladder Cancer — Petros Grivas, MD, PhD (1:21:15)

CME information and select publications